The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.
December 06, 2012
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.
May 04, 2012
Academic medical centers can play a larger role in drug development and testing, according to an FDA official, who says there is a need for better strategies to identify winners, minimize costs and reduce failures during drug development.
November 16, 2011
UCSF’s new robotic pharmacy has won a 2011 Best of What’s New award for innovation from Popular Science.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
September 07, 2011
Researchers with the University of California, San Francisco and the University of California, Merced will examine the effectiveness of state and local anti-smoking programs across the United States to ensure that health authorities are able to use their increasingly limited resources to support and defend the most effective approaches.
August 22, 2011
Children with severe asthma are 3.6 times more likely to have been exposed to tobacco smoking before birth – even without later exposure – than children with a mild form of the disease, according to a multicenter study led by researchers at University of California, San Francisco (UCSF).
June 24, 2011
Tina Brock, who recently became associate dean of teaching and learning in the UCSF School of Pharmacy, offers her perspective on the science of education, the importance of interprofessional learning and teaching future pharmacists.
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
March 28, 2011
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble issued an update on the school's accomplishments, faculty awards and other campus news.